Instrument Inactif

Autres langues THERACLION N Euronext Paris

Actions

FR0010120402

Cours en clôture Euronext Paris Autres places de cotation
- ^EUR	-

28/03	Theraclion : annonce une réduction de sa perte annuelle en 2023	AO
28/03	Y'a tout qui monte (sauf le risque)

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Theraclion Announces 2023 Financial Results and Continues Its Roadmap	27/03
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Theraclion : announces 2023 financial results and continues its roadmap	27/03
Theraclion : Présentation AGM – 29 juin 2023	21/12
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	24/10/23
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	11/10/23
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	28/09/23
Theraclion : Presentation AGM 29 juin 2023	24/07/23
Theraclion : l'augmentation de capital est bouclée	23/06/23
Theraclion SA announced that it has received â‚¬8.353961 million in funding from Furui Medical Science Company Luxembourg S.Ã r.l.	22/06/23
Theraclion Names CEO	26/05/23
Theraclion Appoints Martin Deterre as CEO	25/05/23
Theraclion SA announced that it expects to receive €7 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	25/05/23
Theraclion SA announced that it expects to receive ?12.649999 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	24/05/23
Global markets live: HSBC, Logitech, Uber, IBM, BP...	02/05/23
Bolsa de Madrid: First Republic muerde el polvo a su vez	02/05/23
Theraclion SA Auditor Raises 'Going Concern' Doubt	29/04/23
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	28/04/23
Theraclion : la FDA autorise une étude pivot avec Sonovein	18/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues THERACLION N Euronext Paris

Actions

FR0010120402

Autres langues

Filtres